GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Valneva SE (FRA:AYJ) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Valneva SE (FRA:AYJ) Future 3-5Y EPS without NRI Growth Rate : N/A (As of May. 18, 2025)


View and export this data going back to 2007. Start your Free Trial

What is Valneva SE Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Valneva SE's Future 3-5Y EPS without NRI Growth Rate is N/A.


Competitive Comparison of Valneva SE's Future 3-5Y EPS without NRI Growth Rate

For the Biotechnology subindustry, Valneva SE's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Valneva SE's Future 3-5Y EPS without NRI Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Valneva SE's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Valneva SE's Future 3-5Y EPS without NRI Growth Rate falls into.


;
;

Valneva SE  (FRA:AYJ) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.


Valneva SE Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Valneva SE's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Valneva SE Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Valneva SE (FRA:AYJ) » Definitions » Future 3-5Y EPS without NRI Growth Rate
Address
6 Rue Alain Bombard, Saint-Herblain, FRA, 44800
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Valneva SE Headlines

No Headlines